Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that it has completed the sale of DSM Special Products B.V. to Emerald Performance Materials (owned by an affiliate of Sun Capital Partners), as announced on 3 August 2010.
Â
DSM Special Products is the producer of amongst others Purox B and Purox S®, ingredients used in food and feed products as well as in a range of industrial applications. It also produces VevoVitall®, a product for the animal health market that will continue to be sold by DSM Nutritional Products. DSM Special Products employs around 125 people in Rotterdam and Sittard (Netherlands), and has an annual turnover of approximately EUR 125 million. At closing all employees transfer to the new owner. DSM expects a small book profit as a result of the transaction, which will be recognized in Q4 2010.
Â
Emerald Performance Materials
Emerald Performance Materials, LLC produces and markets technologically advanced specialty chemicals for a broad range of food and industrial applications. Its products play a variety of roles in the products that are consumed and used every day enabling them to last longer, look, smell, taste or perform better. Emerald products are used in aerospace, food, beverages, cosmetics, toothpaste, household products, paint, tires, automobiles, sports gear and many other applications. Headquartered in Cuyahoga Falls, Ohio, Emerald has seven operations and approximately 600 employees.
Â
DSM - the Life Sciences and Materials Sciences Company
Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic performance, environmental quality and social responsibility, which it pursues simultaneously and in parallel. DSM has annual net sales of about €8 billion and employs some 22,700 people worldwide. The company is headquartered in the Netherlands, with locations (http://www.dsm.com/en_US/html/about/location_finder.htm) on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com (http://www.dsm.com/)
Â
For more information:
DSM Corporate CommunicationsHerman Bettentel. +31 (0) 45 5782017Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â fax +31 (0) 45 5740680Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â e-mail media.relations@dsm.com (mailto:media.relations@dsm.com)Â Â Â | DSM Investor RelationsHans Vossentel. +31 (0) 45 5782864 fax +31 (0) 10 4590275 e-mail investor.relations@dsm.com (mailto:investor.relations@dsm.com) |
Â
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: DSM N.V. via Thomson Reuters ONE
HUG#1473276
